Markets:

Overview

News

Currencies

International

Treasuries

Zentalis Pharmaceuticals, Inc. - common stock (NQ:ZNTL)

5.225 -0.335 (-6.03%)

Streaming Delayed Price Updated: 3:19 PM EDT, Apr 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zentalis Pharmaceuticals, Inc. - common stock

< Previous 1 2 3 4 Next >

Stocks That Hit 52-Week Highs On Thursday ↗

August 26, 2021

Before 10 a.m. ET on Thursday, 91 companies hit new 52-week highs. Interesting Points: The largest company by market cap to set a new 52-week high was Alphabet (...

Via Benzinga

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO ↗

August 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...

Via Benzinga

Week In Review: China Life Science Posts $1.3 Billion In Deals ↗

August 07, 2021

Pacific Biosciences, a San Francisco Bay area company offering long-read sequencing platforms, will acquire Omniome for up to $800 million. Zai Lab and Schrödinger formed a collaboration to develop a...

Via Talk Markets

Week In Review: BeiGene Plans $3 Billion IPO On Shanghai STAR Market ↗

July 03, 2021

BeiGene of Beijing has been approved to stage a $3 billion IPO on the Shanghai Star Stock Exchange. It will be the first Chinese biopharma to be listed in Shanghai, Hong Kong, and the US.

Via Talk Markets

Topics Initial Public Offering

The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout ↗

June 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...

Via Benzinga

Zentalis Secures $150M In Equity Funding ↗

June 29, 2021

Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) priced an underwritten public offering of 3.1 million shares at $48.50 per share, for gross proceeds of approximately $...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 28, 2021

Gainers SCWorx (NASDAQ:WORX) shares rose ...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 21, 2021 ↗

May 21, 2021

Upgrades According to JP Morgan, the prior rating for ResMed Inc (NYSE:RMD) was changed from Neutral to Overweight. For the third quarter, ResMed had an EPS of $1.30,...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

May 19, 2021

Barclays reduced Apple Inc. (NASDAQ: AAPL) price target from $138 to $134. Apple shares fell 1.1% to $123.47 in pre-market trading. UBS lifted Wells Fargo & Company (NYSE:...

Via Benzinga

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

April 27, 2021

Tuesday's morning session saw 205 companies set new 52-week highs. Interesting Highlights: Wells Fargo (NYSE:WFC) was the largest firm on a market cap basis to set a...

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

April 13, 2021

Rosenblatt boosted NVIDIA Corporation (NASDAQ: NVDA) price target from $700 to $800. NVIDIA shares fell 0.2% to $607.00 in pre-market trading. Keybanc boosted the price target...

Via Benzinga

The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗

April 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

Zentalis's Early WEE1 Inhibitor Data Shows 'Exceptional' Response In Solid Tumor Study, Plans Combination Trials ↗

April 12, 2021

Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) has announced initial efficacy and safety data from the Phase 1 dose-escalation portion of its ongoing Phase 1/2...

Via Benzinga

38 Stocks Moving In Friday's Mid-Day Session ↗

April 09, 2021

Gainers Celcuity Inc. (NASDAQ: CELC) shares jumped 64.5% to $23.54 after the company announced a worldwide licensing agreement with Pfizer to develop and commercialize...

Via Benzinga

51 Biggest Movers From Friday ↗

April 12, 2021

Gainers Celcuity Inc. (NASDAQ: CELC) shares climbed 50.9% to close at $21.60 on Friday after the company announced a worldwide licensing agreement with Pfizer to develop and...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.